Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 1

Abstract

Background: Cardiovascular manifestations are frequent findings in patients with thyroid hormone disorders. Asymmetric dimethylarginine (ADMA), a inhibitor of endothelial nitric oxide synthase (eNOS), blocks nitric oxide (NO) synthesis from l-arginine. So, ADMA level can be considered as cardiovascular risk marker as it is a possible contributing factors for endothelial dysfunction in hyperthyroid patients. Objectives: The aim of the study was to assess ADMA levels in hyperthyroidism patients free of cardiovascular risk associates and further comparison with healthy controls. Methodology: The study took place in Victoria Hospital, attached to Bangalore Medical College and Research Institute. The study groups consisted of 30 patients with diagnosed hyperthyroidism and 30 healthy sex and age matched controls. The patients with renal failure, diabetes and severe hypertension were excluded. ADMA was estimated by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). Results: The Mean ADMA level was higher in the hyperthyroid group (1.1346±0.6382μmol/L) than in the control group (0.584±0.2377μmol/L) and it was statistically significant (p<0.0001). Conclusion: ADMA represents a new and well-characterized marker that has been associated with many traditional and novel risk factors in the setting of cardiovascular risk. So, an elevation of ADMA levels of patients with hyperthyroidism compared with healthy controls may contribute to some cardiovascular alterations.

Authors and Affiliations

Priyanka Patra, Anitha M. , HL Vishwanath

Keywords

Related Articles

Study of oxidative stress and endothelial dysfunction in paediatric obesity

Introduction: Obesity is associated with complications like Diabetes, Asthma, Hypertension and cardiovascular risks which are to be managed of health care worldwide. Increased BMI during childhood and adolescence may lea...

Influence of maternal nutrition status during pregnancy on developmental outcome in first 30 days of independent neonatal life

Introduction: Birth weight is an important determinant of infant mortality. Two third of all deaths occurring in first twenty eight days of life happen due to low birth weight. LBW infants suffer higher risk of health co...

Study of specimen stability for biochemical parameters

Introduction: The blood sample is collected and transported to the laboratory for analysis, during this time the samples bares many extra-analytical factors prior to analysis. Contact time of plasma or serum with the blo...

Qualitative chemical analysis and incidence of renal stone disease in rural population of South Solapur, Maharashtra

Background: There are many reports regarding renal stone disease, which have documented that it is a complex disease process and widely distributed in developed as well as developing world with varied chemical constituti...

A Multi Marker Evaluation of Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis

Background: Rheumatoid arthritis (RA), an inflammatory joint disease, is also associated with systemic effects. Patients with RA have an increased risk of morbidity and mortality that is mainly attributable to cardiovasc...

Download PDF file
  • EP ID EP295935
  • DOI 10.18231/2394-6377.2017.0023
  • Views 89
  • Downloads 0

How To Cite

Priyanka Patra, Anitha M. , HL Vishwanath (2017). Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre. International Journal of Clinical Biochemistry and Research, 4(1), 99-102. https://europub.co.uk/articles/-A-295935